FDAnews
www.fdanews.com/articles/70098-predix-to-get-12-5-million-for-cystic-fibrosis-research

Predix to Get $12.5 Million for Cystic Fibrosis Research

March 21, 2005

Predix Pharmaceuticals Holdings and Cystic Fibrosis Foundation Therapeutics have signed a research, development and commercialization agreement for two cystic fibrosis drug development programs. The award funds two research programs. The first is focused on the defective cystic fibrosis transmembrane conductance regulator (CFTR) protein. A mutation in the CFTR gene is one of the key factors that ultimately leads to the symptoms, complications and premature mortality in people with cystic fibrosis (CF).

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=dc124974fe00f17f&cat=6dcd932030878143)